TL;DR
In an interview with Being Patient, Columbia radiologist Michael Lipton described how quantitative MRI can measure subtle brain features that may not be visible on routine scans. The techniques are being studied for changes linked to conditions including Alzheimer’s disease and repetitive head impacts, but the source does not establish them as a replacement for standard diagnosis or as a routine clinical test.
Being Patient has published an interview with Dr. Michael Lipton, a Columbia University radiology professor, about research into quantitative MRI methods that can measure subtle brain features not readily visible on routine scans. The discussion addresses why a report describing a conventional MRI as normal does not rule out every brain disorder, and how researchers are investigating quantitative imaging in conditions including Alzheimer’s disease and repetitive head impacts.
Lipton, who is also an attending radiologist at NewYork-Presbyterian, said a conventional brain MRI is interpreted by a radiologist examining images for visible abnormalities. A report that calls a scan “normal” or “unremarkable” describes what could be identified on those images; it does not establish that every aspect of the brain is biologically normal. Routine MRI can identify problems such as a sufficiently large stroke or brain tumor, he said, while some disease-related changes may occur at a microscopic scale.
Quantitative MRI refers to advanced imaging approaches that measure features of brain tissue rather than relying only on visual inspection of standard images. In the interview, Lipton discussed measuring subtle brain volume loss, including changes associated with Alzheimer’s disease. He also described research on the effects of concussions and repetitive head impacts among soccer players. The supplied report does not give study sizes, numerical results or performance measures for these methods.
Lipton said neurological symptoms can persist despite an MRI that appears unremarkable. He distinguished structural injuries that may be visible on a scan from difficulties involving thinking, memory, attention, sleep or other functions, which can involve communication across brain networks and structures too small for routine imaging to resolve. His comments describe the limits of what a standard scan can show, not a conclusion that a particular patient’s symptoms have a specific cause.
Why Routine Scans Can Miss Changes
The distinction matters for patients who have ongoing symptoms but receive a normal MRI report. As Lipton explained, a routine scan is useful for identifying many visible structural problems, but it cannot answer every question about brain function or microscopic tissue changes. A normal result should not be read as proof that symptoms are imagined or that no biological changes exist; equally, it does not by itself show that a hidden disease is present.
Quantitative imaging may add measurable information to visual interpretation, potentially helping researchers study subtle differences over time or between groups. That could be relevant to research on neurodegenerative disease and head impacts. But the interview, as supplied, does not establish that these techniques can diagnose an individual, predict outcomes, or change treatment. Their significance depends on further evidence about accuracy, clinical usefulness and how results should be interpreted.
brain MRI anatomy and neuroscience textbook
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Visual Reading to Measurement
Conventional brain MRI produces multiple types of images and many slices through the head. A radiologist reviews them for abnormalities that can be recognized visually. This approach can be effective for detecting substantial structural problems, but it is not a direct microscopic examination of brain tissue. Lipton compared the limitation to pathology: some conditions may not be apparent even when tissue is examined without a microscope.
Lipton’s work, as described by Being Patient, spans advanced quantitative MRI and research into concussion and repeated impacts in soccer. The interview connects those topics through a shared question: whether measurement beyond what is readily apparent on routine images can reveal brain changes. The source describes the research and its rationale, but the material provided does not include detailed methods, publication references or a timeline for clinical adoption.
“That does not necessarily mean that the brain is normal.”
— Dr. Michael Lipton, professor of radiology at Columbia University Irving Medical Center, in an interview with Being Patient
brain health and cognitive wellness journal
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What the Interview Does Not Establish
The supplied source does not specify which quantitative MRI techniques were used, how well they performed, or whether findings were tested in large, independent groups. It also provides no numerical estimates for sensitivity, specificity or the amount of brain-volume change detected. Without those details, readers cannot assess how reliably the methods distinguish disease-related changes from normal variation.
It remains unclear from the report whether any of the techniques discussed are available in routine clinical care, approved for particular diagnostic uses, or shown to improve decisions for patients. The interview also does not show that quantitative MRI can identify the cause of an individual’s symptoms. Lipton’s comments about persistent symptoms and normal scans are general explanations, not patient-specific diagnoses.
concussion symptom and recovery tracking journal
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence Needed for Clinical Use
The next step for quantitative MRI research is to establish how measurements perform across carefully designed studies and whether they provide information that changes clinical assessment or care. Useful evidence would include clearly reported methods, comparison groups, reproducibility across scanners and sites, and follow-up showing what the measurements mean over time.
No specific next study or clinical milestone is identified in the supplied interview. For now, the report offers an explanation of what routine MRI can and cannot show, alongside a description of research directions. People with persistent neurological symptoms should discuss their situation and any further testing with a qualified health professional; an apparently normal scan alone cannot settle every diagnostic question.
Key Questions
Does a normal brain MRI mean the brain is healthy?
No. As Lipton explained, “normal” generally means the radiologist did not identify an abnormality visible on the images. Some microscopic or functional changes may not appear on a routine scan. A normal result also does not, by itself, establish that a disorder is present.
What does quantitative MRI measure?
Quantitative MRI uses imaging measurements to assess features of brain tissue, rather than relying only on a radiologist’s visual reading of standard images. The interview mentions subtle brain volume loss but does not identify specific measurement protocols or provide performance data.
Can quantitative MRI diagnose Alzheimer’s disease?
The supplied report does not show that quantitative MRI can diagnose Alzheimer’s disease in an individual. It says Lipton discussed research into subtle volume changes associated with the disease; diagnostic accuracy and clinical use are not established in the material provided.
Why can symptoms continue when an MRI looks unremarkable?
Some symptoms may involve brain-cell communication and networks that are too small or complex to be assessed on a routine structural scan. Lipton said that a normal-looking MRI does not rule out every biological brain change, but symptoms require assessment in their clinical context.
Source: rss
